tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FOLD Stock Latest News

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Press ReleasesAmicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
2M ago
FOLD
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product
PremiumPress Releases
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product
2M ago
FOLD
Amicus initiated with an Overweight at Wells Fargo
PremiumThe Fly
Amicus initiated with an Overweight at Wells Fargo
2M ago
FOLD
Amicus upgraded to Buy from Neutral at Guggenheim
PremiumThe Fly
Amicus upgraded to Buy from Neutral at Guggenheim
2M ago
FOLD
Amicus price target lowered to $19 from $20 at UBS
PremiumThe Fly
Amicus price target lowered to $19 from $20 at UBS
2M ago
FOLD
Amicus price target lowered to $13 from $14 at BofA
PremiumThe FlyAmicus price target lowered to $13 from $14 at BofA
2M ago
FOLD
Amicus sees FY24 revenue growth of 25%-30%
PremiumThe Fly
Amicus sees FY24 revenue growth of 25%-30%
2M ago
FOLD
Amicus reports Q1 EPS (16c), consensus (7c)
PremiumThe Fly
Amicus reports Q1 EPS (16c), consensus (7c)
2M ago
FOLD
FOLD Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
FOLD Upcoming Earnings Report: What to Expect?
3M ago
FOLD
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
PremiumPress Releases
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
3M ago
FOLD
Amicus price target lowered to $19 from $21 at JPMorgan
PremiumThe Fly
Amicus price target lowered to $19 from $21 at JPMorgan
4M ago
FOLD
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
PremiumPress Releases
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
5M ago
FOLD
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
PremiumPress ReleasesAmicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
5M ago
FOLD
Amicus reports Q4 EPS 1c, consensus (6c)
PremiumThe Fly
Amicus reports Q4 EPS 1c, consensus (6c)
5M ago
FOLD
FOLD Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
FOLD Upcoming Earnings Report: What to Expect?
5M ago
FOLD
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
PremiumPress Releases
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
5M ago
FOLD
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
PremiumPress Releases
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
5M ago
FOLD
Amicus’ (NASDAQ:FOLD) 2023 Sales Exceed Expectations
PremiumMarket News
Amicus’ (NASDAQ:FOLD) 2023 Sales Exceed Expectations
7M ago
FOLD
Amicus reports preliminary FY23 revenue $399.4M, consensus $396.45M
PremiumThe Fly
Amicus reports preliminary FY23 revenue $399.4M, consensus $396.45M
7M ago
FOLD
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
PremiumPress ReleasesAmicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7M ago
FOLD
‘Time to Pull the Trigger,’ Says Morgan Stanley About These 2 Healthcare Stocks
PremiumStock Analysis & Ideas
‘Time to Pull the Trigger,’ Says Morgan Stanley About These 2 Healthcare Stocks
7M ago
ACAD
FOLD
Amicus upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Amicus upgraded to Overweight from Equal Weight at Morgan Stanley
7M ago
FOLD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >